Topical aprepitant in clinical and experimental pruritus.
Joanna
J
Wallengren
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000932:Antiemetics / Q000494:pharmacology / Q000627:therapeutic use*; D000077608:Aprepitant; D004311:Double-Blind Method; D005260:Female; D006632:Histamine / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use*; D064729:Neurokinin-1 Receptor Antagonists; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy*; D012720:Severity of Illness Index; D014870:Water Loss, Insensible / Q000187:drug effects
D000932:Antiemetics; D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D000077608:Aprepitant; D006632:Histamine